Cargando…
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy
BACKGROUND: CHMP4C is one of the charged multivesicular protein (CHMP), and is involved in the composition of the endosomal sorting complex required for transport III (ESCRT-III), facilitating the necessary separation of daughter cells. CHMP4C has been proposed to be involved in the progression of d...
Autores principales: | Zhang, Hongtuan, Liu, Dongze, Qin, Zheng, Yi, Bocun, Zhu, Liang, Xu, Shengxian, Wang, Kaibin, Yang, Shaobo, Liu, Ranlu, Yang, Kuo, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301743/ https://www.ncbi.nlm.nih.gov/pubmed/37388224 http://dx.doi.org/10.3389/fonc.2023.1170397 |
Ejemplares similares
-
Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs
por: Liu, Dongze, et al.
Publicado: (2022) -
Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer
por: Sun, Guangyu, et al.
Publicado: (2022) -
Pan-cancer analysis of the prognostic and immunological role of PAQR4
por: Wang, Kaibin, et al.
Publicado: (2022) -
Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022) -
Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
por: Zhang, Hongtuan, et al.
Publicado: (2012)